Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice—Real‐world evidence from the inflammatory bowel …

F D'Amico, F Gomollón, G Bamias… - United European …, 2024 - Wiley Online Library
Background Crohn's disease and ulcerative colitis (UC) are inflammatory bowel diseases
(IBD) characterized by a progressive nature of the disease resulting in subsequent intestinal …

IBD-PODCAST Spain: a close look at current daily clinical practice in IBD management

P Vega, JM Huguet, E Gómez, S Rubio… - Digestive Diseases and …, 2024 - Springer
Background Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel
diseases (IBD) that contributes in part to irreversible bowel damage and long-term …

Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial

J Siffledeen, S Singh, SM Shulman, J Igoe… - Digestive Diseases and …, 2024 - Springer
Background The real-world application of STRIDE-II treatment targets to identify whether
disease control is optimal in Crohn's disease (CD) and ulcerative colitis (UC) is not well …

[HTML][HTML] Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil

LY Sassaki, SJ Miszputen, RLK Junior… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel
diseases (IBDs) with a remission-relapsing presentation and symptomatic exacerbations …

[HTML][HTML] Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?

L Gonczi, T Bessissow, PL Lakatos - World journal of …, 2019 - ncbi.nlm.nih.gov
In recent years, there has been a critical change in treatment paradigms in inflammatory
bowel diseases (IBD) triggered by the arrival of new effective treatments aiming to prevent …

Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE

HW Fiske, C Ward, SA Shah, SD Holubar… - Crohn's & Colitis …, 2024 - academic.oup.com
Background Since 2009, inflammatory bowel disease (IBD) specialists have utilized “IBD
LIVE,” a weekly live video conference with a global audience, to discuss the multidisciplinary …

Un‐promoted issues in inflammatory bowel disease: opportunities to optimize care

JM Andrews, RE Mountifield… - Internal medicine …, 2010 - Wiley Online Library
Inflammatory bowel diseases (IBD), comprising Crohn's disease (CD) and ulcerative colitis
(UC), are chronic inflammatory disorders of the gut, which lead to significant morbidity and …

Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD

C Le Berre, L Peyrin-Biroulet, WJ Sandborn… - Gastroenterology, 2021 - Elsevier
Background and Aims Inflammatory bowel diseases (IBD), encompassing Crohn's disease
(CD) and ulcerative colitis (UC), are chronic and disabling disorders. Prospective disease …

Burden of disease among patients with prevalent Crohn's disease: results from a large German sickness fund

E Zhuleku, B Antolin-Fontes, A Borsi… - International Journal of …, 2023 - Springer
Purpose The aim of this study was to investigate the burden of disease among a real-world
cohort of patients with prevalent Crohn's disease (CD) in Germany. Methods We conducted …

Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease

J West, K Tan, J Devi, F Macrae, B Christensen… - Journal of Clinical …, 2023 - mdpi.com
There is notable disparity between symptomatology and disease activity in a significant
proportion of patients with inflammatory bowel disease (IBD), and escalation of treatment …